 | Form 4 Filings | Insider Buys | Significant Buys | Penny Stocks Insider Buying | Insider Sales |
| Insider Buy Sell Ratios | Stock Options | Insider Trading Stock Screener | Insider Trading Graph View | Insider Watch |
Insider Trading - Intra-Cellular Therapies Inc. (ITCI)
| | "Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise" - Peter Lynch What is insider trading>> SPAC List: List of Special Purpose Acquisition Companies |
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2020-09-14 Purchase | 2020-09-14 5:03 pm | Intra-Cellular Therapies Inc. | ITCI | Alafi Christopher D Director | 49,500 | $29.6 | $1,465,200 | 4,743,770 (Indirect Direct) | View |
| 2020-10-15 Sale | 2020-10-16 4:04 pm | Intra-Cellular Therapies Inc. | ITCI | Neumann Mark EVP Chief Commercial Officer | 6,792 | $26.8 | $182,026 | 28,120 (Direct) | View |
| 2020-11-04 Sale | 2020-11-06 6:00 pm | Intra-Cellular Therapies Inc. | ITCI | Mates Sharon CEO Chairman | 50,000 | $25 | $1,250,000 | 1,163,392 (Direct) | View |
| 2020-11-10 Sale | 2020-11-12 5:51 pm | Intra-Cellular Therapies Inc. | ITCI | Mates Sharon CEO Chairman | 50,000 | $26.34 | $1,317,101 | 1,113,392 (Direct) | View |
| 2020-11-11 Sale | 2020-11-13 5:51 pm | Intra-Cellular Therapies Inc. | ITCI | Hineline Lawrence J. CFO | 28,034 | $25.41 | $712,344 | 0 (Direct) | View |
| 2020-11-17 Sale | 2020-11-19 8:05 pm | Intra-Cellular Therapies Inc. | ITCI | Halstead Michael VP | 79,425 | $27.62 | $2,193,446 | 0 (Direct) | View |
| 2021-01-03 Sale | 2021-01-05 6:09 pm | Intra-Cellular Therapies Inc. | ITCI | Mates Sharon CEO Chairman | 48,341 | $31.3 | $1,513,271 | 1,133,392 (Direct) | View |
| 2021-01-03 Sale | 2021-01-05 6:11 pm | Intra-Cellular Therapies Inc. | ITCI | Halstead Michael VP | 16,160 | $31.3 | $505,834 | 0 (Direct) | View |
| 2021-01-03 Sale | 2021-01-05 6:13 pm | Intra-Cellular Therapies Inc. | ITCI | Hineline Lawrence J. CFO | 15,810 | $31.31 | $495,008 | 350 (Direct) | View |
| 2021-01-08 Sale | 2021-01-12 7:01 pm | Intra-Cellular Therapies Inc. | ITCI | Mates Sharon CEO Chairman | 41,896 | $32.01 | $1,341,260 | 1,133,392 (Direct) | View |
| 2021-01-08 Sale | 2021-01-12 7:03 pm | Intra-Cellular Therapies Inc. | ITCI | Halstead Michael VP | 19,638 | $32.03 | $628,978 | 0 (Direct) | View |
| 2021-01-08 Sale | 2021-01-12 7:05 pm | Intra-Cellular Therapies Inc. | ITCI | Hineline Lawrence J. CFO | 19,638 | $32.02 | $628,769 | 0 (Direct) | View |
| 2021-01-08 Sale | 2021-01-12 7:06 pm | Intra-Cellular Therapies Inc. | ITCI | Neumann Mark EVP Chief Commercial Officer | 9,684 | $32.02 | $310,082 | 39,384 (Direct) | View |
| 2021-01-08 Sale | 2021-01-12 7:07 pm | Intra-Cellular Therapies Inc. | ITCI | Durgam Suresh K. Chief Medical Officer | 4,367 | $32.12 | $140,259 | 17,484 (Direct) | View |
| 2021-02-18 Sale | 2021-02-22 8:01 pm | Intra-Cellular Therapies Inc. | ITCI | Mates Sharon CEO Chairman | 27,847 | $39.23 | $1,092,436 | 1,133,392 (Direct) | View |
| 2021-02-18 Sale | 2021-02-22 8:03 pm | Intra-Cellular Therapies Inc. | ITCI | Halstead Michael VP | 11,139 | $39.24 | $437,133 | 0 (Direct) | View |
| 2021-02-18 Sale | 2021-02-22 8:05 pm | Intra-Cellular Therapies Inc. | ITCI | Hineline Lawrence J. CFO | 10,442 | $39.23 | $409,625 | 0 (Direct) | View |
| 2021-02-18 Sale | 2021-02-22 8:07 pm | Intra-Cellular Therapies Inc. | ITCI | Neumann Mark EVP Chief Commercial Officer | 5,184 | $39.22 | $203,308 | 45,339 (Direct) | View |
| 2021-02-18 Sale | 2021-02-22 8:09 pm | Intra-Cellular Therapies Inc. | ITCI | Durgam Suresh K. Chief Medical Officer | 2,734 | $39.25 | $107,310 | 23,104 (Direct) | View |
| 2021-03-02 Sale | 2021-03-04 5:43 pm | Intra-Cellular Therapies Inc. | ITCI | MARCUS JOEL S Director | 15,250 | $34.93 | $532,683 | 72,269 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2020-09-30 Option Award | 2020-10-02 4:13 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | Alafi Christopher D Director | 613 | $25.66 | 345,836 (Direct) | View |
| 2020-09-30 Option Award | 2020-10-02 4:17 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | LERNER RICHARD A Director | 584 | $25.66 | 94,981 (Indirect) | View |
| 2020-09-30 Option Award | 2020-10-02 4:22 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | RIGGS RORY B Director | 613 | $25.66 | 60,982 (Direct) | View |
| 2020-09-30 Option Award | 2020-10-02 4:24 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | VAN NOSTRAND ROBERT L Director | 276 | $25.66 | 7,843 (Direct) | View |
| 2020-10-15 Exercise | 2020-10-16 4:04 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | Neumann Mark EVP Chief Commercial Officer | 13,448 | $0 | 34,912 (Direct) | View |
| 2020-10-15 Exercise | 2020-10-16 4:04 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | Neumann Mark EVP Chief Commercial Officer | 13,448 | $0 | 13,448 (Direct) | View |
| 2020-11-11 Exercise | 2020-11-13 5:51 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | Hineline Lawrence J. CFO | 10,000 | $2.84 | 18,034 (Direct) | View |
| 2020-11-11 Exercise | 2020-11-13 5:51 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | Hineline Lawrence J. CFO | 10,000 | $3.26 | 28,034 (Direct) | View |
| 2020-11-11 Exercise | 2020-11-13 5:51 pm | N/A 2022-04-30 | Intra-Cellular Therapies Inc. | ITCI | Hineline Lawrence J. CFO | 10,000 | $0 | 0 (Direct) | View |
| 2020-11-11 Exercise | 2020-11-13 5:51 pm | N/A 2023-05-30 | Intra-Cellular Therapies Inc. | ITCI | Hineline Lawrence J. CFO | 10,000 | $0 | 0 (Direct) | View |
| 2020-11-17 Exercise | 2020-11-19 8:05 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | Halstead Michael VP | 75,000 | $13.86 | 79,425 (Direct) | View |
| 2020-11-17 Exercise | 2020-11-19 8:05 pm | N/A 2024-07-29 | Intra-Cellular Therapies Inc. | ITCI | Halstead Michael VP | 75,000 | $0 | 25,000 (Direct) | View |
| 2020-12-17 Gift | 2020-12-18 4:07 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | MARCUS JOEL S Director | 28,379 | $0 | 0 (Direct) | View |
| 2020-12-17 Gift | 2020-12-18 4:07 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | MARCUS JOEL S Director | 28,379 | $0 | 67,519 (Indirect) | View |
| 2020-12-17 Gift | 2020-12-18 4:07 pm | N/A 2025-06-16 | Intra-Cellular Therapies Inc. | ITCI | MARCUS JOEL S Director | 20,000 | $0 | 0 (Direct) | View |
| 2020-12-17 Gift | 2020-12-18 4:07 pm | N/A 2025-06-16 | Intra-Cellular Therapies Inc. | ITCI | MARCUS JOEL S Director | 20,000 | $0 | 20,000 (Indirect) | View |
| 2020-12-17 Gift | 2020-12-18 4:07 pm | N/A 2026-06-14 | Intra-Cellular Therapies Inc. | ITCI | MARCUS JOEL S Director | 20,000 | $0 | 0 (Direct) | View |
| 2020-12-17 Gift | 2020-12-18 4:07 pm | N/A 2026-06-14 | Intra-Cellular Therapies Inc. | ITCI | MARCUS JOEL S Director | 20,000 | $0 | 20,000 (Indirect) | View |
| 2020-12-18 Exercise | 2020-12-21 4:03 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | Mates Sharon CEO Chairman | 34,000 | $2.74 | 1,147,392 (Direct) | View |
| 2020-12-18 Exercise | 2020-12-21 4:03 pm | N/A 2020-12-21 | Intra-Cellular Therapies Inc. | ITCI | Mates Sharon CEO Chairman | 34,000 | $0 | 0 (Direct) | View |
| 2020-12-31 Option Award | 2021-01-05 6:01 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | Alafi Christopher D Director | 495 | $31.8 | 346,331 (Direct) | View |
| 2020-12-31 Option Award | 2021-01-05 6:03 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | RIGGS RORY B Director | 495 | $31.8 | 61,477 (Direct) | View |
| 2020-12-31 Option Award | 2021-01-05 6:05 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | VAN NOSTRAND ROBERT L Director | 222 | $31.8 | 8,065 (Direct) | View |
| 2020-12-31 Option Award | 2021-01-05 6:07 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | LERNER RICHARD A Director | 471 | $31.8 | 95,452 (Indirect) | View |
| 2021-01-03 Exercise | 2021-01-05 6:09 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | Mates Sharon CEO Chairman | 34,341 | $0 | 1,181,733 (Direct) | View |
| 2021-01-03 Exercise | 2021-01-05 6:09 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | Mates Sharon CEO Chairman | 34,341 | $0 | 0 (Direct) | View |
| 2021-01-03 Exercise | 2021-01-05 6:11 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | Halstead Michael VP | 16,160 | $0 | 16,160 (Direct) | View |
| 2021-01-03 Exercise | 2021-01-05 6:11 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | Halstead Michael VP | 16,160 | $0 | 0 (Direct) | View |
| 2021-01-03 Exercise | 2021-01-05 6:13 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | Hineline Lawrence J. CFO | 16,160 | $0 | 16,160 (Direct) | View |
| 2021-01-03 Exercise | 2021-01-05 6:13 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | Hineline Lawrence J. CFO | 16,160 | $0 | 0 (Direct) | View |
| 2021-01-08 Exercise | 2021-01-12 7:01 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | Mates Sharon CEO Chairman | 41,896 | $0 | 1,175,288 (Direct) | View |
| 2021-01-08 Exercise | 2021-01-12 7:01 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | Mates Sharon CEO Chairman | 41,896 | $0 | 41,896 (Direct) | View |
| 2021-01-08 Exercise | 2021-01-12 7:03 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | Halstead Michael VP | 19,638 | $0 | 19,638 (Direct) | View |
| 2021-01-08 Exercise | 2021-01-12 7:03 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | Halstead Michael VP | 19,638 | $0 | 19,639 (Direct) | View |
| 2021-01-08 Gift | 2021-01-12 7:05 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | Hineline Lawrence J. CFO | 350 | $0 | 0 (Direct) | View |
| 2021-01-08 Exercise | 2021-01-12 7:05 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | Hineline Lawrence J. CFO | 19,638 | $0 | 19,638 (Direct) | View |
| 2021-01-08 Exercise | 2021-01-12 7:05 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | Hineline Lawrence J. CFO | 19,638 | $0 | 19,639 (Direct) | View |
| 2021-01-08 Exercise | 2021-01-12 7:06 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | Neumann Mark EVP Chief Commercial Officer | 20,948 | $0 | 49,068 (Direct) | View |
| 2021-01-08 Exercise | 2021-01-12 7:06 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | Neumann Mark EVP Chief Commercial Officer | 20,948 | $0 | 20,948 (Direct) | View |
| 2021-01-08 Exercise | 2021-01-12 7:07 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | Durgam Suresh K. Chief Medical Officer | 13,092 | $0 | 21,851 (Direct) | View |
| 2021-01-08 Exercise | 2021-01-12 7:07 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | Durgam Suresh K. Chief Medical Officer | 13,092 | $0 | 13,093 (Direct) | View |
| 2021-02-18 Exercise | 2021-02-22 8:01 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | Mates Sharon CEO Chairman | 27,847 | $0 | 1,161,239 (Direct) | View |
| 2021-02-18 Exercise | 2021-02-22 8:01 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | Mates Sharon CEO Chairman | 27,847 | $0 | 55,695 (Direct) | View |
| 2021-02-18 Exercise | 2021-02-22 8:03 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | Halstead Michael VP | 11,139 | $0 | 11,139 (Direct) | View |
| 2021-02-18 Exercise | 2021-02-22 8:03 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | Halstead Michael VP | 11,139 | $0 | 22,278 (Direct) | View |
| 2021-02-18 Exercise | 2021-02-22 8:05 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | Hineline Lawrence J. CFO | 10,442 | $0 | 10,442 (Direct) | View |
| 2021-02-18 Exercise | 2021-02-22 8:05 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | Hineline Lawrence J. CFO | 10,442 | $0 | 20,886 (Direct) | View |
| 2021-02-18 Exercise | 2021-02-22 8:07 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | Neumann Mark EVP Chief Commercial Officer | 11,139 | $0 | 50,523 (Direct) | View |
| 2021-02-18 Exercise | 2021-02-22 8:07 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | Neumann Mark EVP Chief Commercial Officer | 11,139 | $0 | 22,278 (Direct) | View |
| 2021-02-18 Exercise | 2021-02-22 8:09 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | Durgam Suresh K. Chief Medical Officer | 8,354 | $0 | 25,838 (Direct) | View |
| 2021-02-18 Exercise | 2021-02-22 8:09 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | Durgam Suresh K. Chief Medical Officer | 8,354 | $0 | 16,708 (Direct) | View |
| 2021-02-23 Option Award | 2021-02-25 4:01 pm | N/A 2031-02-22 | Intra-Cellular Therapies Inc. | ITCI | Mates Sharon CEO Chairman | 53,471 | $0 | 53,471 (Direct) | View |
| 2021-02-23 Option Award | 2021-02-25 4:01 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | Mates Sharon CEO Chairman | 67,769 | $0 | 67,769 (Direct) | View |
| 2021-02-23 Option Award | 2021-02-25 4:12 pm | N/A 2031-02-22 | Intra-Cellular Therapies Inc. | ITCI | Halstead Michael VP | 18,714 | $0 | 18,714 (Direct) | View |
| 2021-02-23 Option Award | 2021-02-25 4:12 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | Halstead Michael VP | 23,719 | $0 | 23,719 (Direct) | View |
| 2021-02-23 Option Award | 2021-02-25 4:20 pm | N/A 2031-02-22 | Intra-Cellular Therapies Inc. | ITCI | Hineline Lawrence J. CFO | 17,644 | $0 | 17,644 (Direct) | View |
| 2021-02-23 Option Award | 2021-02-25 4:20 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | Hineline Lawrence J. CFO | 22,364 | $0 | 22,364 (Direct) | View |
| 2021-02-23 Option Award | 2021-02-25 4:24 pm | N/A 2031-02-22 | Intra-Cellular Therapies Inc. | ITCI | Neumann Mark EVP Chief Commercial Officer | 18,714 | $0 | 18,714 (Direct) | View |
| 2021-02-23 Option Award | 2021-02-25 4:24 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | Neumann Mark EVP Chief Commercial Officer | 23,719 | $0 | 23,719 (Direct) | View |
| 2021-02-23 Option Award | 2021-02-25 4:28 pm | N/A 2031-02-22 | Intra-Cellular Therapies Inc. | ITCI | Durgam Suresh K. Chief Medical Officer | 18,714 | $0 | 18,714 (Direct) | View |
| 2021-02-23 Option Award | 2021-02-25 4:28 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | Durgam Suresh K. Chief Medical Officer | 23,719 | $0 | 23,719 (Direct) | View |
| 2021-03-02 Exercise | 2021-03-04 5:43 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | MARCUS JOEL S Director | 20,000 | $26.58 | 87,519 (Indirect) | View |
| 2021-03-02 Exercise | 2021-03-04 5:43 pm | N/A 2025-06-16 | Intra-Cellular Therapies Inc. | ITCI | MARCUS JOEL S Director | 20,000 | $0 | 0 (Indirect) | View |
| 2021-03-31 Option Award | 2021-04-02 5:26 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | VAN NOSTRAND ROBERT L Director | 208 | $33.93 | 8,273 (Direct) | View |
| 2021-03-31 Option Award | 2021-04-02 5:27 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | Alafi Christopher D Director | 464 | $33.93 | 346,795 (Direct) | View |
| 2021-03-31 Option Award | 2021-04-02 5:29 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | RIGGS RORY B Director | 464 | $33.93 | 61,941 (Direct) | View |
| 2021-03-31 Option Award | 2021-04-02 5:31 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | LERNER RICHARD A Director | 442 | $33.93 | 95,894 (Indirect) | View |
| 2021-04-12 Gift | 2021-04-14 4:05 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | MARCUS JOEL S Director | 25,000 | $0 | 47,269 (Indirect) | View |